Stoyanova Lab News
Exciting News: Dr. Shiqin (Laura) Liu is promoted to Assistant Adjunct Professor
Dr. Shiqin Liu has been promoted to Assistant Adjunct Professor at the Department of Molecular and Medical Pharmacology at the University of California, Los Angeles!
Congratulations Laura!
Biofabrication of prostate cancer-like 3D models utilizing co-axial hydrogel spinning
Stoyanova lab is excited to share our new publication in Biofabrication on using Co-axial hydrogel spinning technology for facile biofabrication of 3D prostate cancer models, in collaboration with Dr. Utkan Demirci’s lab.
Congratulations!
Link to Publication: https://iopscience.iop.org/article/10.1088/1758-5090/ad2535
UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas
Stoyanova lab is excited to share our new publication on Cell Reports Medicine on revealing mechanisms of UCHL1 function in regulating the progression of neuroendocrine carcinomas and identifying UCHL1 as a therapeutic target and potential molecular indicator for diagnosing and monitoring treatment responses in these malignancies.
Congratulations!
Link to Publication: https://www.cell.com/cell-reports-medicine/pdf/S2666-3791(23)00610-9.pdf
High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker
Stoyanova lab is excited to share our new work on identifying Trop2 protein as a novel prognostic tissue biomarker and non-invasive urinary biomarker for prostate cancer.
Congratulations!
Link to Publication: https://www.nature.com/articles/s41598-023-50215-z
Welcome Hyeonji Hwang, a postdoctoral scholar from Seoul National University, to the lab!
Welcome to Dr. Stoyanova’s lab, Hyeonji!
Exciting News: Dr. Shiqin (Laura) Liu Receives Eula and Donald S. Coffey Innovative Research Award
Dr. Shiqin (Laura) Liu receives the Eula and Donald S. Coffey Innovative Research Award for her research discoveries and talk “UCHL1 is a Molecular Indicator and a Therapeutic Target for Neuroendocrine Prostate Cancer” at the Society for Basic Urological Research (SBUR) annual conference.
Congratulations, Laura!
Welcome Ziyi Chen, a postdoctoral scholar from The first Affiliated Hospital of Nanjing Medical University, to the lab!
Welcome to Dr. Stoyanova’s lab, Ziyi!
Exciting News: Dr. Alifiani Bonita Hartono wins Second Place at the UCLA Molecular and Medical Pharmacology Departmental Retreat
Dr. Alifiani Bonita Hartono wins second place poster award for her project titled “Utilizing High-Throughput Screening of Small Compounds to Develop Inhibitors for Aggressive Prostate Cancer”, at the Molecular and Medical Pharmacology Departmental Retreat.
Congratulations, Bonita!
ACAA2 is a novel molecular indicator for cancers with neuroendocrine phenotype
Stoyanova lab is excited to share our study on identifying ACAA2 as a potential new molecular indicator for cancers with neuroendocrine phenotype. Congratulations!
Link to publication: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667239/
